Commercializing Science

Blog

From Discovery to Market

All Posts
technology transferlicensing

Why Option Agreements Are the Most Misused Tool in Technology Transfer

Option agreements should de-risk early licensing deals, but most TTOs use them wrong. Here's what's broken and how to fix it.

A. Kovacs A. Kovacs
· · 4 min read
tech transferinvention disclosure

Why Most Invention Disclosure Forms Kill Commercialization Before It Starts

Invention disclosure forms are often the first step in tech transfer, and one of the most damaging. Here's what needs to change.

A. Kovacs A. Kovacs
· · 4 min read
technology transferTRL

Why Most Technology Readiness Level Assessments Lie to Everyone Involved

TRL scores feel objective but are routinely gamed or misread. Here's what's really happening and how to use them honestly.

A. Kovacs A. Kovacs
· · 5 min read
spinoutsequity

Why Most Startup Equity Structures Break University Spinouts Before They Launch

Equity splits between founders, universities, and early investors derail more spinouts than bad science. Here's what actually works.

A. Kovacs A. Kovacs
· · 4 min read
technology transfersponsored research

Why Sponsored Research Agreements Are Where Commercialization Actually Begins

Sponsored research agreements shape IP ownership, licensing rights, and spinout potential before a patent is ever filed. Here's what most researchers miss.

A. Kovacs A. Kovacs
· · 4 min read
proof of concepttechnology transfer

Why Proof-of-Concept Funding Is the Leverage Point Nobody Talks About

Proof-of-concept funding is the missing bridge between lab discovery and licensable technology, here's why most institutions underinvest in it.

A. Kovacs A. Kovacs
· · 4 min read
technology transferlicensing

Why Most Licensing Term Sheets Die in Negotiation (And How to Rescue Them)

Most university licensing deals collapse not because of bad science or bad intent, but because of preventable negotiation failures. Here's what actually goes wrong.

A. Kovacs A. Kovacs
· · 5 min read
spinoutsventure-capital

Why Due Diligence Kills More University Spinouts Than Bad Science

How mismatched expectations between VCs and university spinouts create a death spiral during due diligence.

A. Kovacs A. Kovacs
· · 4 min read
patent licensinguniversity metrics

Why Patent Licensing Revenue Is a Vanity Metric (And What Universities Should Track Instead)

Patent licensing revenue misleads universities about tech transfer success, here's what metrics actually predict commercial impact.

A. Kovacs A. Kovacs
· · 4 min read
corporate-venture-capitaluniversity-spinouts

Why Corporate Venture Arms Keep Missing the Best University Deals

Corporate VCs systematically lose out on promising university spinouts due to misaligned incentives and poor deal sourcing strategies.

A. Kovacs A. Kovacs
· · 4 min read
industry partnershipsuniversity research

Why Industry-University Research Partnerships Fail (And the Three Models That Actually Work)

Most industry-university partnerships collapse within two years. Here's why most fail and three proven models that deliver results.

A. Kovacs A. Kovacs
· · 4 min read
academic-spinoutstechnology-transfer

Why Academic Inventors Make Terrible CEOs (And What to Do About It)

Most university spinouts fail because brilliant researchers become accidental executives without proper transition support.

A. Kovacs A. Kovacs
· · 4 min read
technology-transferuniversity-commercialization

Why Most University Tech Transfer Offices Are Optimizing for the Wrong Metrics

University TTOs focus on licensing revenue and patent counts instead of startup success and economic impact.

A. Kovacs A. Kovacs
· · 4 min read
tech transfervalley of death

The Valley of Death Is Real and We're Still Not Talking About It Honestly

University research dies between the lab and the market at staggering rates. The reasons are structural, not accidental, and most proposed fixes miss the point entirely.

A. Kovacs A. Kovacs
· · 3 min read
SBIRSTTR

Why SBIR/STTR Is the Most Underrated Funding Mechanism

SBIR and STTR grants offer non-dilutive funding with built-in customer discovery, yet most technical founders overlook them. That is a mistake.

A. Kovacs A. Kovacs
· · 3 min read